Acasti pharma recognizes rare disease day

Laval, qc , feb. 28, 2023 /prnewswire/ -- acasti pharma inc. ("acasti" or the "company") (nasdaq: acst and tsx-v: acst), a late-stage, specialty pharma company advancing three clinical stage drug candidates addressing rare and orphan diseases, recognizes and celebrates rare disease day (february 28), as established by the european organization for rare diseases. "rare diseases impact approximately 300 million patients around the world and are often chronic, progressive and frequently life-threatening," commented jan d'alvise, ceo of acasti pharma.
ACST Ratings Summary
ACST Quant Ranking